Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oncology Treatment Drug market report explains the definition, types, applications, major countries, and major players of the Oncology Treatment Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Astellas
Pfizer
Johnson & Johnson
Otsuka
Novartis
AbbVie
Gilead Sciences
Roche
Merck & Co
Ipsen
Amgen
Takeda
Teva
AstraZeneca
Merck KGaA
Eisai
Celgene
Sanofi
Biogen Idec
Bayer
Eli Lilly
Bristol-Myers Squibb
By Type:
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
By End-User:
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Oncology Treatment Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Oncology Treatment Drug Outlook to 2028- Original Forecasts
-
2.2 Oncology Treatment Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Oncology Treatment Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Oncology Treatment Drug Market- Recent Developments
-
6.1 Oncology Treatment Drug Market News and Developments
-
6.2 Oncology Treatment Drug Market Deals Landscape
7 Oncology Treatment Drug Raw Materials and Cost Structure Analysis
-
7.1 Oncology Treatment Drug Key Raw Materials
-
7.2 Oncology Treatment Drug Price Trend of Key Raw Materials
-
7.3 Oncology Treatment Drug Key Suppliers of Raw Materials
-
7.4 Oncology Treatment Drug Market Concentration Rate of Raw Materials
-
7.5 Oncology Treatment Drug Cost Structure Analysis
-
7.5.1 Oncology Treatment Drug Raw Materials Analysis
-
7.5.2 Oncology Treatment Drug Labor Cost Analysis
-
7.5.3 Oncology Treatment Drug Manufacturing Expenses Analysis
8 Global Oncology Treatment Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Oncology Treatment Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Oncology Treatment Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Oncology Treatment Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Oncology Treatment Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immunotherapy (Biologic Therapy) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncology Treatment Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Oncology Treatment Drug Market Analysis and Outlook till 2022
-
10.1 Global Oncology Treatment Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Oncology Treatment Drug Consumption (2017-2022)
-
10.2.2 Canada Oncology Treatment Drug Consumption (2017-2022)
-
10.2.3 Mexico Oncology Treatment Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Oncology Treatment Drug Consumption (2017-2022)
-
10.3.2 UK Oncology Treatment Drug Consumption (2017-2022)
-
10.3.3 Spain Oncology Treatment Drug Consumption (2017-2022)
-
10.3.4 Belgium Oncology Treatment Drug Consumption (2017-2022)
-
10.3.5 France Oncology Treatment Drug Consumption (2017-2022)
-
10.3.6 Italy Oncology Treatment Drug Consumption (2017-2022)
-
10.3.7 Denmark Oncology Treatment Drug Consumption (2017-2022)
-
10.3.8 Finland Oncology Treatment Drug Consumption (2017-2022)
-
10.3.9 Norway Oncology Treatment Drug Consumption (2017-2022)
-
10.3.10 Sweden Oncology Treatment Drug Consumption (2017-2022)
-
10.3.11 Poland Oncology Treatment Drug Consumption (2017-2022)
-
10.3.12 Russia Oncology Treatment Drug Consumption (2017-2022)
-
10.3.13 Turkey Oncology Treatment Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Oncology Treatment Drug Consumption (2017-2022)
-
10.4.2 Japan Oncology Treatment Drug Consumption (2017-2022)
-
10.4.3 India Oncology Treatment Drug Consumption (2017-2022)
-
10.4.4 South Korea Oncology Treatment Drug Consumption (2017-2022)
-
10.4.5 Pakistan Oncology Treatment Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Oncology Treatment Drug Consumption (2017-2022)
-
10.4.7 Indonesia Oncology Treatment Drug Consumption (2017-2022)
-
10.4.8 Thailand Oncology Treatment Drug Consumption (2017-2022)
-
10.4.9 Singapore Oncology Treatment Drug Consumption (2017-2022)
-
10.4.10 Malaysia Oncology Treatment Drug Consumption (2017-2022)
-
10.4.11 Philippines Oncology Treatment Drug Consumption (2017-2022)
-
10.4.12 Vietnam Oncology Treatment Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Oncology Treatment Drug Consumption (2017-2022)
-
10.5.2 Colombia Oncology Treatment Drug Consumption (2017-2022)
-
10.5.3 Chile Oncology Treatment Drug Consumption (2017-2022)
-
10.5.4 Argentina Oncology Treatment Drug Consumption (2017-2022)
-
10.5.5 Venezuela Oncology Treatment Drug Consumption (2017-2022)
-
10.5.6 Peru Oncology Treatment Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Oncology Treatment Drug Consumption (2017-2022)
-
10.5.8 Ecuador Oncology Treatment Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Oncology Treatment Drug Consumption (2017-2022)
-
10.6.2 Kuwait Oncology Treatment Drug Consumption (2017-2022)
-
10.6.3 Oman Oncology Treatment Drug Consumption (2017-2022)
-
10.6.4 Qatar Oncology Treatment Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Oncology Treatment Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Oncology Treatment Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Oncology Treatment Drug Consumption (2017-2022)
-
10.7.2 South Africa Oncology Treatment Drug Consumption (2017-2022)
-
10.7.3 Egypt Oncology Treatment Drug Consumption (2017-2022)
-
10.7.4 Algeria Oncology Treatment Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Oncology Treatment Drug Consumption (2017-2022)
-
10.8.2 New Zealand Oncology Treatment Drug Consumption (2017-2022)
11 Global Oncology Treatment Drug Competitive Analysis
-
11.1 Astellas
-
11.1.1 Astellas Company Details
-
11.1.2 Astellas Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Astellas Oncology Treatment Drug Main Business and Markets Served
-
11.1.4 Astellas Oncology Treatment Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer
-
11.2.1 Pfizer Company Details
-
11.2.2 Pfizer Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer Oncology Treatment Drug Main Business and Markets Served
-
11.2.4 Pfizer Oncology Treatment Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Johnson & Johnson
-
11.3.1 Johnson & Johnson Company Details
-
11.3.2 Johnson & Johnson Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Johnson & Johnson Oncology Treatment Drug Main Business and Markets Served
-
11.3.4 Johnson & Johnson Oncology Treatment Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Otsuka
-
11.4.1 Otsuka Company Details
-
11.4.2 Otsuka Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Otsuka Oncology Treatment Drug Main Business and Markets Served
-
11.4.4 Otsuka Oncology Treatment Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Novartis
-
11.5.1 Novartis Company Details
-
11.5.2 Novartis Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Novartis Oncology Treatment Drug Main Business and Markets Served
-
11.5.4 Novartis Oncology Treatment Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 AbbVie
-
11.6.1 AbbVie Company Details
-
11.6.2 AbbVie Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 AbbVie Oncology Treatment Drug Main Business and Markets Served
-
11.6.4 AbbVie Oncology Treatment Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Gilead Sciences
-
11.7.1 Gilead Sciences Company Details
-
11.7.2 Gilead Sciences Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Gilead Sciences Oncology Treatment Drug Main Business and Markets Served
-
11.7.4 Gilead Sciences Oncology Treatment Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Roche
-
11.8.1 Roche Company Details
-
11.8.2 Roche Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Roche Oncology Treatment Drug Main Business and Markets Served
-
11.8.4 Roche Oncology Treatment Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Merck & Co
-
11.9.1 Merck & Co Company Details
-
11.9.2 Merck & Co Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Merck & Co Oncology Treatment Drug Main Business and Markets Served
-
11.9.4 Merck & Co Oncology Treatment Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Ipsen
-
11.10.1 Ipsen Company Details
-
11.10.2 Ipsen Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Ipsen Oncology Treatment Drug Main Business and Markets Served
-
11.10.4 Ipsen Oncology Treatment Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Amgen
-
11.11.1 Amgen Company Details
-
11.11.2 Amgen Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Amgen Oncology Treatment Drug Main Business and Markets Served
-
11.11.4 Amgen Oncology Treatment Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Takeda
-
11.12.1 Takeda Company Details
-
11.12.2 Takeda Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Takeda Oncology Treatment Drug Main Business and Markets Served
-
11.12.4 Takeda Oncology Treatment Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Teva
-
11.13.1 Teva Company Details
-
11.13.2 Teva Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Teva Oncology Treatment Drug Main Business and Markets Served
-
11.13.4 Teva Oncology Treatment Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 AstraZeneca
-
11.14.1 AstraZeneca Company Details
-
11.14.2 AstraZeneca Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 AstraZeneca Oncology Treatment Drug Main Business and Markets Served
-
11.14.4 AstraZeneca Oncology Treatment Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Merck KGaA
-
11.15.1 Merck KGaA Company Details
-
11.15.2 Merck KGaA Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Merck KGaA Oncology Treatment Drug Main Business and Markets Served
-
11.15.4 Merck KGaA Oncology Treatment Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Eisai
-
11.16.1 Eisai Company Details
-
11.16.2 Eisai Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Eisai Oncology Treatment Drug Main Business and Markets Served
-
11.16.4 Eisai Oncology Treatment Drug Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Celgene
-
11.17.1 Celgene Company Details
-
11.17.2 Celgene Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Celgene Oncology Treatment Drug Main Business and Markets Served
-
11.17.4 Celgene Oncology Treatment Drug Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Sanofi
-
11.18.1 Sanofi Company Details
-
11.18.2 Sanofi Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Sanofi Oncology Treatment Drug Main Business and Markets Served
-
11.18.4 Sanofi Oncology Treatment Drug Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Biogen Idec
-
11.19.1 Biogen Idec Company Details
-
11.19.2 Biogen Idec Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Biogen Idec Oncology Treatment Drug Main Business and Markets Served
-
11.19.4 Biogen Idec Oncology Treatment Drug Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Bayer
-
11.20.1 Bayer Company Details
-
11.20.2 Bayer Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Bayer Oncology Treatment Drug Main Business and Markets Served
-
11.20.4 Bayer Oncology Treatment Drug Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Eli Lilly
-
11.21.1 Eli Lilly Company Details
-
11.21.2 Eli Lilly Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Eli Lilly Oncology Treatment Drug Main Business and Markets Served
-
11.21.4 Eli Lilly Oncology Treatment Drug Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Bristol-Myers Squibb
-
11.22.1 Bristol-Myers Squibb Company Details
-
11.22.2 Bristol-Myers Squibb Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Bristol-Myers Squibb Oncology Treatment Drug Main Business and Markets Served
-
11.22.4 Bristol-Myers Squibb Oncology Treatment Drug Product Portfolio
-
11.22.5 Recent Research and Development Strategies
12 Global Oncology Treatment Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Oncology Treatment Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Immunotherapy (Biologic Therapy) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Oncology Treatment Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Oncology Treatment Drug Market Analysis and Outlook to 2028
-
13.1 Global Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.5 France Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.3 India Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Oncology Treatment Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Oncology Treatment Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Oncology Treatment Drug
-
Figure of Oncology Treatment Drug Picture
-
Table Global Oncology Treatment Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Oncology Treatment Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy (Biologic Therapy) Consumption and Growth Rate (2017-2022)
-
Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Treatment Drug Consumption by Country (2017-2022)
-
Table North America Oncology Treatment Drug Consumption by Country (2017-2022)
-
Figure United States Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Oncology Treatment Drug Consumption by Country (2017-2022)
-
Figure Germany Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure France Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Oncology Treatment Drug Consumption by Country (2017-2022)
-
Figure China Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure India Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Table South America Oncology Treatment Drug Consumption by Country (2017-2022)
-
Figure Brazil Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Oncology Treatment Drug Consumption by Country (2017-2022)
-
Figure Bahrain Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Oncology Treatment Drug Consumption by Country (2017-2022)
-
Figure Nigeria Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Oncology Treatment Drug Consumption by Country (2017-2022)
-
Figure Australia Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Oncology Treatment Drug Consumption and Growth Rate (2017-2022)
-
Table Astellas Company Details
-
Table Astellas Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Oncology Treatment Drug Main Business and Markets Served
-
Table Astellas Oncology Treatment Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Oncology Treatment Drug Main Business and Markets Served
-
Table Pfizer Oncology Treatment Drug Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Oncology Treatment Drug Main Business and Markets Served
-
Table Johnson & Johnson Oncology Treatment Drug Product Portfolio
-
Table Otsuka Company Details
-
Table Otsuka Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Oncology Treatment Drug Main Business and Markets Served
-
Table Otsuka Oncology Treatment Drug Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Oncology Treatment Drug Main Business and Markets Served
-
Table Novartis Oncology Treatment Drug Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Oncology Treatment Drug Main Business and Markets Served
-
Table AbbVie Oncology Treatment Drug Product Portfolio
-
Table Gilead Sciences Company Details
-
Table Gilead Sciences Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Oncology Treatment Drug Main Business and Markets Served
-
Table Gilead Sciences Oncology Treatment Drug Product Portfolio
-
Table Roche Company Details
-
Table Roche Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Oncology Treatment Drug Main Business and Markets Served
-
Table Roche Oncology Treatment Drug Product Portfolio
-
Table Merck & Co Company Details
-
Table Merck & Co Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Oncology Treatment Drug Main Business and Markets Served
-
Table Merck & Co Oncology Treatment Drug Product Portfolio
-
Table Ipsen Company Details
-
Table Ipsen Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Oncology Treatment Drug Main Business and Markets Served
-
Table Ipsen Oncology Treatment Drug Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Oncology Treatment Drug Main Business and Markets Served
-
Table Amgen Oncology Treatment Drug Product Portfolio
-
Table Takeda Company Details
-
Table Takeda Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Oncology Treatment Drug Main Business and Markets Served
-
Table Takeda Oncology Treatment Drug Product Portfolio
-
Table Teva Company Details
-
Table Teva Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Oncology Treatment Drug Main Business and Markets Served
-
Table Teva Oncology Treatment Drug Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Oncology Treatment Drug Main Business and Markets Served
-
Table AstraZeneca Oncology Treatment Drug Product Portfolio
-
Table Merck KGaA Company Details
-
Table Merck KGaA Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Oncology Treatment Drug Main Business and Markets Served
-
Table Merck KGaA Oncology Treatment Drug Product Portfolio
-
Table Eisai Company Details
-
Table Eisai Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Oncology Treatment Drug Main Business and Markets Served
-
Table Eisai Oncology Treatment Drug Product Portfolio
-
Table Celgene Company Details
-
Table Celgene Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Oncology Treatment Drug Main Business and Markets Served
-
Table Celgene Oncology Treatment Drug Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Oncology Treatment Drug Main Business and Markets Served
-
Table Sanofi Oncology Treatment Drug Product Portfolio
-
Table Biogen Idec Company Details
-
Table Biogen Idec Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Oncology Treatment Drug Main Business and Markets Served
-
Table Biogen Idec Oncology Treatment Drug Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Oncology Treatment Drug Main Business and Markets Served
-
Table Bayer Oncology Treatment Drug Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Oncology Treatment Drug Main Business and Markets Served
-
Table Eli Lilly Oncology Treatment Drug Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Oncology Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Oncology Treatment Drug Main Business and Markets Served
-
Table Bristol-Myers Squibb Oncology Treatment Drug Product Portfolio
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy (Biologic Therapy) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Treatment Drug Consumption Forecast by Country (2022-2028)
-
Table North America Oncology Treatment Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncology Treatment Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Oncology Treatment Drug Consumption Forecast by Country (2022-2028)
-
Figure China Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Oncology Treatment Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Oncology Treatment Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Oncology Treatment Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Oncology Treatment Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Oncology Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
